🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
The incidence of melanoma is increasing with an estimated incidence of 59,9...
Status
Completed
Location
New York University Langone Medical Center
Start Date
2010-09
Trial ID
NCT01079741
Treatments Being Tested
RATIONALE: Vaccines made from peptides may make the body build an immune re...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2003-10-28
Trial ID
NCT00070070
Treatments Being Tested
The hope is that the peptide vaccines will stimulate the immune system to a...
Status
Completed
Location
University of Arkansas for Medical Sciences/MIRT
Start Date
2004-06
Trial ID
NCT00090493
Treatments Being Tested
This phase I trial studies the side effects and immune response to DEC-205/...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2013-07-30
Trial ID
NCT01834248
Treatments Being Tested
This phase I trial studies the best dose and side effects of NY-ESO-1 T cel...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2019-03-08
Trial ID
NCT03691376
Treatments Being Tested
Gastric cancer is one of the leading causes of cancer-related deaths worldw...
Status
Suspended
Location
Multiple Locations
Start Date
2010-03
Trial ID
NCT02686424
The study is designed to see if a course of injections containing the NY-ES...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2009-02
Trial ID
NCT00821652
This pilot phase I trial studies the side effects of taking ipilimumab afte...
Status
Terminated
Location
Jonsson Comprehensive Cancer Center
Start Date
2014-07-17
Trial ID
NCT02070406
This phase I trial studies the side effects of DEC-205/NY-ESO-1 fusion prot...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2018-03-27
Trial ID
NCT03358719